Jubilant Pharmova Ltd - 530019 - Update On Acquisition Of Stake In O2 Renewable Energy XVI Private Limited
Update on Acquisition of Stake in O2 Renewable Energy XVI Private Limited06-06-2024
06-06-2024
Jubilant Pharmova Ltd - 530019 - Update On Disposal Of Investment In Sofie Biosciences Inc., USA By Jubilant Pharma Limited, Singapore, A Wholly Owned Subsidiary Of Jubilant Pharmova Limited
Update on disposal of invesment in Sofie Biosciences Inc., USA by Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of Jubilant Pharmova Limited05-06-2024
Jubilant Pharmova Ltd - 530019 - Resignation Letter Of Mr. Jinang Pratap Parekh, Whole-Time Director Of The Company
Resignation letter of Mr. Jinang Pratap Parekh, Whole-Time Director of the Company03-06-2024
Jubilant Pharmova Ltd - 530019 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year 2023-2430-05-2024
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper publication of Audited Standalone and Consolidated financial results for the quarter and year ended March 31, 202430-05-2024
Q4FY24 Quarterly & FY24 Annual Result Announced for Jubilant Pharmova Ltd.
Pharmaceuticals company Jubilant Pharmova announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Total income: Rs 1,773 crore (5% increase compared to Q4FY23) Reported EBITDA: Rs 289 crore (20% increase compared to Q4FY23) EBITDA margin: 16.3% (Increased by 200 basis points compared to Q4FY23) Normalized PAT: Rs 61 crore (122% decrease compared to Q4FY23) FY24 Financial Highlights: Total income: Rs 6,772 crore (7% increase compared to FY23) Reported EBITDA: Rs 994 crore (20% increase compared to FY23) EBITDA margin: 14.7% (Increased by 160 basis points compared to FY23) Normalized PAT: Rs 195 crore (63% increase compared to FY23) The Board of Jubilant Pharmova Limited met today to approve financial result for the quarter and financial year ended Mar 31, 2024. The board has proposed a dividend of Rs 5 per equity share. Result PDF29-05-2024
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated May 29, 202429-05-2024
Jubilant Pharmova Ltd - 530019 - Intimation Of Record Date - August 02, 2024
Intimation of Record Date - August 02, 202429-05-2024
Jubilant Pharmova Ltd - 530019 - Corporate Action-Board approves Dividend
Recommendation of final dividend29-05-2024
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Directorate
Change in Directorate29-05-2024